Mariano Provencio
Mariano Provencio
Hospital Universitario Puerta de Hierro. Universidad Autónoma de Madrid.
Dirección de correo verificada de salud.madrid.org
Título
Citado por
Citado por
Año
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre …
R Rosell, E Carcereny, R Gervais, A Vergnenegre, B Massuti, E Felip, ...
The lancet oncology 13 (3), 239-246, 2012
4347*2012
Screening for epidermal growth factor receptor mutations in lung cancer
R Rosell, T Moran, C Queralt, R Porta, F Cardenal, C Camps, M Majem, ...
New England Journal of Medicine 361 (10), 958-967, 2009
23832009
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non–small-cell lung cancer
M Cobo, D Isla, B Massuti, A Montes, JM Sanchez, M Provencio, ...
Journal of clinical oncology 25 (19), 2747-2754, 2007
6212007
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
R Rosell, KD Danenberg, V Alberola, G Bepler, JJ Sanchez, C Camps, ...
Clinical Cancer Research 10 (4), 1318-1325, 2004
5202004
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group
E Zucca, A Conconi, TI Mughal, AH Sarris, JF Seymour, U Vitolo, R Klasa, ...
Journal of Clinical Oncology 21 (1), 20-27, 2003
4602003
Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations
JM Silva, G Dominguez, JM Garcia, R Gonzalez, MJ Villanueva, ...
Cancer research 59 (13), 3251-3256, 1999
3301999
Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non–small-cell lung cancer patients with EGFR mutations
R Rosell, MA Molina, C Costa, S Simonetti, A Gimenez-Capitan, ...
Clinical Cancer Research 17 (5), 1160-1168, 2011
2982011
Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non–small-cell lung cancer: A Spanish Lung Cancer Group phase III …
V Alberola, C Camps, M Provencio, D Isla, R Rosell, C Vadell, I Bover, ...
Journal of clinical oncology 21 (17), 3207-3213, 2003
2582003
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
JM García, J Silva, C Pena, V Garcia, R Rodríguez, MA Cruz, B Cantos, ...
Genes, Chromosomes and Cancer 41 (2), 117-124, 2004
2522004
Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival
J Silva, V García, A Zaballos, M Provencio, L Lombardía, L Almonacid, ...
European Respiratory Journal 37 (3), 617-623, 2011
2382011
A prospective phase II trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients (p) with mutations in the tyrosine kinase (TK) domain of the epidermal growth …
L Paz-Ares, JM Sanchez, A Garcia-Velasco, B Massuti, G Lopez-Vivanco, ...
Journal of Clinical Oncology 24 (18_suppl), 7020-7020, 2006
2292006
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression
R Rosell, L Perez-Roca, JJ Sanchez, M Cobo, T Moran, I Chaib, ...
PloS one 4 (5), 2009
2162009
Cancer antigen 125 associated with multiple benign and malignant pathologies
C Miralles, M Orea, P Espana, M Provencio, A Sanchez, B Cantos, ...
Annals of Surgical Oncology 10 (2), 150-154, 2003
1922003
Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics
JM Silva, G Dominguez, J Silva, JM Garcia, A Sanchez, O Rodriguez, ...
Clinical cancer research 7 (9), 2821-2825, 2001
1782001
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
C Camps, B Massuti, A Jimenez, I Maestu, RG Gómez, D Isla, ...
Annals of Oncology 17 (3), 467-472, 2006
1652006
Cancer‐associated fibroblast and M 2 macrophage markers together predict outcome in colorectal cancer patients
M Herrera, A Herrera, G Domínguez, J Silva, V García, JM García, ...
Cancer science 104 (4), 437-444, 2013
1622013
Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival
JM Silva, J Silva, A Sanchez, JM Garcia, G Dominguez, M Provencio, ...
Clinical Cancer Research 8 (12), 3761-3766, 2002
1582002
Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells
JM Silva, R Rodriguez, JM Garcia, C Munoz, J Silva, G Dominguez, ...
Gut 50 (4), 530-534, 2002
1582002
Aberrant DNA methylation of the p16 INK4a gene in plasma DNA of breast cancer patients
JM Silva, G Dominguez, MJ Villanueva, R Gonzalez, JM Garcia, ...
British journal of cancer 80 (8), 1262-1264, 1999
1571999
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
A Sánchez-Aguilera, C Montalbán, P de la Cueva, L Sánchez-Verde, ...
Blood 108 (2), 662-668, 2006
1522006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20